MABVAX THERAPEUTICS HLDGS
(55414P702)
Funds Reporting Holdings of MABVAX THERAPEUTICS HLDGS according to 13F filings
Firm Name | Shares Held / Principal Amount | Market Value | Option | Report Period | Effectiveness Date |
---|---|---|---|---|---|
Cambridge Investment Research Advisors Inc | 582,855 | $29k | Jun 30, 2019 | Aug 15, 2019 |